Arthrosamid 2.5% PAAG – The Human Equivalent

Arthrosamid is the 2.5% polyacrylamide hydrogel developed as a long-acting intra-articular injection for the treatment of osteoarthritis in humans. Arthrosamid® is a new type of treatment for knee osteoarthritis that…

Use of Arthramid Vet in Canine Intra-articular injections

Nupsala Learning Resources in the UK recently published a webinar on Canine Intra-articular Injection. Dr Karen Cook BA VetMB BSc (Hons) MRCVS presents an informative webinar on the injection technique…

Treatment of intercarpal (knee) joint lameness in TB racehorses

Use Of a 2.5% Cross-Linked Polyacrylamide Hydrogel In The Management Of Joint Lameness In a Population Of Flat Racing Thoroughbreds: A Pilot Sudy Published in JEVS; Read here Abstract Osteoarthritis…

Clinical Safety of Arthramid Vet 2.5% PAAG Hydrogel

Multiple studies have now shown that 2.5% PAAG is safe for use in animals and humans. Both in vitro and in vivo studies have taken place, designed to generate data…

Arthramid Vet 2.5% PAAG Hydrogel- Efficacy Study

Intra-articular administration of a 2.5% polyacrylamide hydrogel (PAAG- Arthramid Vet) is shown to reduce or abolish lameness in distal interphalangeal (coffin) and metacarpo/ metatarso- phalangeal (fetlock) joints in horses undertaking…

Arthramid Vet 2.5% PAAG – Mechanism Of Action

The mechanism of action of 2.5% PAAG appears multifaceted. Osteoarthritis (OA) describes inflammation of a joint and occurs after single or repetitive episodes of trauma. The term incorporates synovitis, capsulitis,…

Interested in talking to us and learning more?

Schedule a time with one of our experts
BOOK NOW